Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name RO7198457
Trade Name
Synonyms RG 6180|RG-6180|RG6180|RO-7198457|RO 7198457
Drug Descriptions

RO7198457 is a personalized neoantigen-specific immunotherapy that stimulates T-cell mediated immune response against tumor cells, potentially resulting in antitumor activity (Cancer Res (2020) 80 (16_Supplement): CT301).

CAS Registry Number NA
NCIT ID C140162


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + RO7198457 Atezolizumab Fluorouracil Irinotecan Leucovorin Oxaliplatin RO7198457 0 1
Atezolizumab + RO7198457 Atezolizumab RO7198457 0 2
Pembrolizumab + RO7198457 Pembrolizumab RO7198457 0 1
RO7198457 RO7198457 0 2

Additional content available in CKB BOOST